ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”

October 28, 1994

Saul Rivin Receives ACCC Clinical Research Award.

December 1, 2000

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004